Market Research Logo

Gabon Pharmaceuticals and Healthcare Report Q4 2017

Gabon Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

The lack of domestic drug manufacturers in Gabon remains an issue. Locally producedmedicines remain underrepresented and drug shortages are commonplace. The country runs a negativetrade balance much like its Sub-Saharan African neighbours. While we expect to see government incentivesthat will encourage the local production of pharmaceuticals to be put in place, medicine shortages willpersist, especially in rural areas.

Headline Expenditure Projections

Pharmaceuticals: XAF51.2bn (USD86mn) in 2016 to XAF53.2bn (USD89mn) in 2017; +3.9% in localcurrency and 3.3% in US dollar terms. Forecast in US dollar terms revised slightly up from last quarter.

Healthcare: XAF329.1bn (USD555mn) in 2016 to XAF349.7bn (USD586mn) in 2017; +6.3% in localcurrency and 5.7% in US dollar terms. Forecast in US dollar terms revised upwards from last quarter.

Latest Updates

Moroccan drugmaker Pharma 5 launched a new copy Hepatitis B medication tenofovir, which will be 10times cheaper than the branded version, according to the manufacturer. Previously Pharma 5manufactured and launched three hepatitis C medications, Le SSB 400 (Sofosbuvir), Dakasvir(Daclatasvir), and Rivabir (Ribavirine) in several African countries including Gabon.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Gabon 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Gabon 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts local currency (Gabon 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts (Gabon 2015-2021)
Industry Risk/Reward Index
Sub-Saharan Africa Pharmaceuticals: Small Market Sizes Weaken Attractiveness To Innovative Drugmakers
Regulatory Review
Regulatory Environment
Regulatory Regime
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Demographic Forecast
Table: Population Headline Indicators (Gabon 1990-2025)
Table: Key Population Ratios (Gabon 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Gabon 1990-2025)
Table: Population By Age Group (Gabon 1990-2025)
Table: Population By Age Group % (Gabon 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report